| Literature DB >> 34651584 |
Barbara Terzic1, M Felicia Davatolhagh2, Yugong Ho1, Sheng Tang1, Yu-Ting Liu1, Zijie Xia1, Yue Cui1, Marc V Fuccillo2, Zhaolan Zhou1.
Abstract
CDKL5 deficiency disorder (CDD) is an early onset, neurodevelopmental syndrome associated with pathogenic variants in the X-linked gene encoding cyclin-dependent kinase-like 5 (CDKL5). CDKL5 has been implicated in neuronal synapse maturation, yet its postdevelopmental necessity and the reversibility of CDD-associated impairments remain unknown. We temporally manipulated endogenous Cdkl5 expression in male mice and found that postdevelopmental loss of CDKL5 disrupts numerous behavioral domains, hippocampal circuit communication, and dendritic spine morphology, demonstrating an indispensable role for CDKL5 in the adult brain. Accordingly, restoration of Cdkl5 after the early stages of brain development using a conditional rescue mouse model ameliorated CDD-related behavioral impairments and aberrant NMDA receptor signaling. These findings highlight the requirement of CDKL5 beyond early development, underscore the potential for disease reversal in CDD, and suggest that a broad therapeutic time window exists for potential treatment of CDD-related deficits.Entities:
Keywords: Development; Genetic diseases; Neurological disorders; Neuroscience; Synapses
Mesh:
Substances:
Year: 2021 PMID: 34651584 PMCID: PMC8516470 DOI: 10.1172/JCI143655
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808